Ending Alzheimer’s in Our Lifetime: From Genes to Therapies

Posted August 6, 2014

Rudy Tanzi, Ph.D., professor of neurology at Harvard Medical School, presents “Ending Alzheimer’s in Our Lifetime: From Genes to Therapies” on July 10, 2014 at the Martha’s Vineyard Hebrew Center’s Summer Institute.

Alzheimer's therapy Understanding Alzheimer's Videos

Mission Critical: Save the Synapses

Back to News and Events

‘A Marriage to Remember’: Short Documentary by Banker White

Protecting Synapses in Adults: An Early Intervention for Alzheimer’s?

Alzstream™ Webinar: Bringing Gamma Secretase Modulators to Trials

Ending Alzheimer’s in Our Lifetime: From Genes to Therapies

Inside the Alzheimer’s Lab: Interviews With Our Researchers

December 19 2013

Circadian Clock Proteins a Potential Therapeutic Target for Alzheimer’s

October 4 2013

Desperate For a Cure: The Search for New Alzheimer’s Treatments

Ending Alzheimer’s in Our Lifetime: From Genes to Therapies

Share:

Related Content:

Protecting Synapses in Adults: An Early Intervention for Alzheimer’s?

Alzstream™ Webinar: Bringing Gamma Secretase Modulators to Trials

Ending Alzheimer’s in Our Lifetime: From Genes to Therapies

Inside the Alzheimer’s Lab: Interviews With Our Researchers

Circadian Clock Proteins a Potential Therapeutic Target for Alzheimer’s

Desperate For a Cure: The Search for New Alzheimer’s Treatments